- Home
- ICCC vs SWVL Comparison
ICCC vs SWVL Comparison
Compare ICCC & SWVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCC
- SWVL
- Stock Information
- Founded
- ICCC 1982
- SWVL 2017
- Country
- ICCC United States
- SWVL United Arab Emirates
- Employees
- ICCC N/A
- SWVL 284
- Industry
- ICCC Biotechnology: Pharmaceutical Preparations
- SWVL Business Services
- Sector
- ICCC Health Care
- SWVL Consumer Discretionary
- Exchange
- ICCC Nasdaq
- SWVL Nasdaq
- Market Cap
- ICCC 46.2M
- SWVL 46.5M
- IPO Year
- ICCC 1987
- SWVL N/A
- Fundamental
- Price
- ICCC $6.83
- SWVL $4.76
- Analyst Decision
- ICCC
- SWVL
- Analyst Count
- ICCC 0
- SWVL 0
- Target Price
- ICCC N/A
- SWVL N/A
- AVG Volume (30 Days)
- ICCC 27.2K
- SWVL 21.2K
- Earning Date
- ICCC 05-14-2025
- SWVL 06-10-2025
- Dividend Yield
- ICCC N/A
- SWVL N/A
- EPS Growth
- ICCC N/A
- SWVL N/A
- EPS
- ICCC N/A
- SWVL N/A
- Revenue
- ICCC $27,302,766.00
- SWVL $17,207,362.00
- Revenue This Year
- ICCC N/A
- SWVL N/A
- Revenue Next Year
- ICCC N/A
- SWVL N/A
- P/E Ratio
- ICCC N/A
- SWVL N/A
- Revenue Growth
- ICCC 28.29
- SWVL N/A
- 52 Week Low
- ICCC $3.34
- SWVL $2.40
- 52 Week High
- ICCC $6.95
- SWVL $10.87
- Technical
- Relative Strength Index (RSI)
- ICCC 74.94
- SWVL 65.52
- Support Level
- ICCC $6.00
- SWVL $4.51
- Resistance Level
- ICCC $6.95
- SWVL $4.89
- Average True Range (ATR)
- ICCC 0.39
- SWVL 0.42
- MACD
- ICCC 0.12
- SWVL 0.04
- Stochastic Oscillator
- ICCC 94.12
- SWVL 86.23
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
About SWVL Swvl Holdings Corp
Swvl Holdings Corp is a technology-driven mobility company that aims to provide reliable, safe, cost-effective and environmentally responsible mass transit solutions. It provides mobility solutions for enterprises and government and individual commuters across-multiple markets with clients such as Amazon, Bosch, E&, P&G and Siemens. The Company operates in Egypt, Saudi Arabia and the UAE.